Surgery alone is currently still accepted as the principal therapy for cure for patients with localized non-small cell lung cancer. The optimal therapy in locally advanced and unresectable stage III disease remains unclear. The limited performance of each single therapeutic strategy (surgery, radiotherapy, or chemotherapy) in the treatment of locally advanced non-small cell lung cancer accounted for the rationale of the many attempts at improvement by integrating the different approaches. In recent years, to improve clinical outcome, chemotherapy or chemoradiation followed by surgery, and definitive chemoradiation have commonly been used. Despite numerous phase-II trials, little evidence from randomized phase-III trials has been generated. The ongoing randomized trials will probably provide more reliable indications to define the management of the large number of patients with locally advanced disease.

Induction therapy before surgery for non-small cell lung cancer / Ferraldeschi, Roberta; D'Auria, Giuliana; P., Ceratti Ade; P., Assalone; L., Mentuccia; M., Ciprotti; M. L., Evangelista; Mazzoli, Marta; C., Di Fonzo; Cortesi, Enrico. - In: RAYS. - ISSN 0390-7740. - 29:4(2004), pp. 445-452.

Induction therapy before surgery for non-small cell lung cancer

FERRALDESCHI, ROBERTA;D'AURIA, GIULIANA;MAZZOLI, MARTA;CORTESI, Enrico
2004

Abstract

Surgery alone is currently still accepted as the principal therapy for cure for patients with localized non-small cell lung cancer. The optimal therapy in locally advanced and unresectable stage III disease remains unclear. The limited performance of each single therapeutic strategy (surgery, radiotherapy, or chemotherapy) in the treatment of locally advanced non-small cell lung cancer accounted for the rationale of the many attempts at improvement by integrating the different approaches. In recent years, to improve clinical outcome, chemotherapy or chemoradiation followed by surgery, and definitive chemoradiation have commonly been used. Despite numerous phase-II trials, little evidence from randomized phase-III trials has been generated. The ongoing randomized trials will probably provide more reliable indications to define the management of the large number of patients with locally advanced disease.
combined modality therapy; induction therapy; neoadjuvant chemotherapy; non-small cell lung cancer
01 Pubblicazione su rivista::01a Articolo in rivista
Induction therapy before surgery for non-small cell lung cancer / Ferraldeschi, Roberta; D'Auria, Giuliana; P., Ceratti Ade; P., Assalone; L., Mentuccia; M., Ciprotti; M. L., Evangelista; Mazzoli, Marta; C., Di Fonzo; Cortesi, Enrico. - In: RAYS. - ISSN 0390-7740. - 29:4(2004), pp. 445-452.
File allegati a questo prodotto
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/80639
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? 0
  • Scopus 0
  • ???jsp.display-item.citation.isi??? ND
social impact